Pharmacists in Gardner, Massachusetts


30 Pharmacists found in Gardner
female pharmacist

Laura Ivonne Mapes, RPH


Pharmacist
314 Main St, Gardner, MA 01440
978-632-1760     978-630-0100

female pharmacist

Lena Yacoubian, PHARMD


Pharmacist
232 Main St, Gardner, MA 01440
978-630-2808    

male pharmacist

Matthew Robert Menard, PHARMD


Pharmacist
314 Main St, Gardner, MA 01440
978-632-1760    



female pharmacist

Megan Moncecchi, PHARMD


Pharmacist
232 Main St, Gardner, MA 01440
413-281-0526    

female pharmacist

Melissa Lynn Como, PHARMD, RPH


Pharmacist
52 Pearson Blvd, Gardner, MA 01440
978-632-4818    

female pharmacist

Nanthida Soukseunchay, PHARMD


Pharmacist
314 Main St, Gardner, MA 01440
978-632-1760     978-630-0100

female pharmacist

Priscila L Neto, PHARMD


Pharmacist
560 Main St, Gardner, MA 01440
978-730-1040    

female pharmacist

Sarah Willey, PHARMD


Pharmacist
232 Main St, Gardner, MA 01440
978-630-2808    

male pharmacist

Steve Richard


Pharmacist
314 Main St, Gardner, MA 01440
978-632-1760    

female pharmacist

Mrs. Susan Elaine Chevarie


Pharmacist
314 Main St, Gardner, MA 01440
978-632-1760    

female pharmacist

Taylor Sylvester, RPH


Pharmacist
314 Main St, Gardner, MA 01440
978-632-1760    

female pharmacist

Teresa Croteau, PHARMD


Pharmacist
314 Main St, Gardner, MA 01440
978-632-1760    

male pharmacist

Timothy Thebeau


Pharmacist
232 Main St, Gardner, MA 01440
978-630-2808    

male pharmacist

Dr. Zachariah C Logiodice, PHARMD


Pharmacist - Pharmacotherapy
242 Green St, Gardner, MA 01440
978-632-3420    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.